Mega LifeSciences Sustainability Profile
Mega LifeSciences, also known as Mega We Care, is a prominent player in the healthcare industry, headquartered in Thailand. Founded in 1985, the company has established a strong presence across Southeast Asia, with significant operations in countries such as Myanmar, Vietnam, and Malaysia. Specialising in the development and distribution of high-quality pharmaceuticals, dietary supplements, and herbal products, Mega LifeSciences is recognised for its commitment to innovation and quality. The company’s unique formulations and extensive product range cater to diverse health needs, setting it apart in a competitive market. With a focus on enhancing health and well-being, Mega LifeSciences has achieved notable milestones, including numerous certifications and awards that underscore its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Mega LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mega LifeSciences's score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mega LifeSciences's reported carbon emissions
In 2023, Mega LifeSciences, headquartered in Thailand, reported total carbon emissions of approximately 9,000,980 kg CO2e. This figure includes 1,808,570 kg CO2e from Scope 1 emissions, 6,752,890 kg CO2e from Scope 2 emissions, and 439,530 kg CO2e from Scope 3 emissions. The company's emissions data reflects a comprehensive approach to tracking its carbon footprint across all relevant scopes. Over the past few years, Mega LifeSciences has shown a commitment to reducing its carbon emissions. In 2021, the total emissions for Scope 1 and 2 were reported at 6,840,000 kg CO2e, indicating a significant increase in emissions by 2023. However, specific reduction targets or initiatives have not been disclosed, and there are no current Science-Based Targets Initiative (SBTi) reduction targets or climate pledges noted. The emissions data for Mega LifeSciences is cascaded from its parent company, Mega Lifesciences Public Company Limited, reflecting a corporate family relationship. This cascading of data ensures that the emissions reporting aligns with the broader sustainability goals of the organisation. Overall, while Mega LifeSciences has made strides in emissions tracking, further clarity on reduction initiatives and targets would enhance its climate commitment narrative.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 0,000,000 |
| Scope 2 | - | - | - | - | 0,000,000 |
| Scope 3 | - | - | - | - | 000,000 |
How Carbon Intensive is Mega LifeSciences's Industry?
How Carbon Intensive is Mega LifeSciences's Location?
Mega LifeSciences's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mega LifeSciences has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.